Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan

Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies considered past influenza infection when assessing the VE of repeated vaccination. Prospective surveillance was conducted from 2009 to 2012 at a com...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 35; no. 4; pp. 687 - 693
Main Authors Saito, Nobuo, Komori, Kazuhiro, Suzuki, Motoi, Morimoto, Kounosuke, Kishikawa, Takayuki, Yasaka, Takahiro, Ariyoshi, Koya
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 23.01.2017
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies considered past influenza infection when assessing the VE of repeated vaccination. Prospective surveillance was conducted from 2009 to 2012 at a community hospital on a small island in Japan. The study included all outpatients with an influenza-like illness (ILI) who attended the hospital, and a rapid diagnostic test (RDT) was used to diagnose influenza A/B infection. The VE of trivalent inactivated influenza vaccine (TIV) against medically attended influenza A (MA-fluA) was estimated using a test-negative case-control study design. The influence of TIV in the prior season on VE in the current season was investigated in the context of MA-fluA during the prior season. During the three influenza seasons, 5838 ILI episodes (4127 subjects) were analysed. Subjects who had an episode of MA-fluA in the prior season were at a significantly lower risk of MA-fluA in the current season (adjusted odds ratio: 0.38, 95% CI: 0.30–0.50). The overall adjusted VE was 28% (95% CI, 14–40). VE was substantially lower in subjects vaccinated in the prior season compared to those who had not been vaccinated in prior season (19%; 95% CI: 0–35 vs 46%; 95% CI: 26–60, test for interaction, P value <0.05). In subjects who did not have MA-fluA in the prior season showed the attenuation of VE due to repeated vaccination (13%; 95% CI: −7 to 30 vs 44%; 95% CI: 24–59, test for interaction, P<0.05). However this effect was not detected in subjects who had contracted MA-fluA in the prior season. Negative effects of repeated vaccination were significant among those without history of MA-fluA in the prior season.
AbstractList Background Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies considered past influenza infection when assessing the VE of repeated vaccination. Methods Prospective surveillance was conducted from 2009 to 2012 at a community hospital on a small island in Japan. The study included all outpatients with an influenza-like illness (ILI) who attended the hospital, and a rapid diagnostic test (RDT) was used to diagnose influenza A/B infection. The VE of trivalent inactivated influenza vaccine (TIV) against medically attended influenza A (MA-fluA) was estimated using a test-negative case-control study design. The influence of TIV in the prior season on VE in the current season was investigated in the context of MA-fluA during the prior season. Results During the three influenza seasons, 5838 ILI episodes (4127 subjects) were analysed. Subjects who had an episode of MA-fluA in the prior season were at a significantly lower risk of MA-fluA in the current season (adjusted odds ratio: 0.38, 95% CI: 0.30-0.50). The overall adjusted VE was 28% (95% CI, 14-40). VE was substantially lower in subjects vaccinated in the prior season compared to those who had not been vaccinated in prior season (19%; 95% CI: 0-35 vs 46%; 95% CI: 26-60, test for interaction, P value <0.05). In subjects who did not have MA-fluA in the prior season showed the attenuation of VE due to repeated vaccination (13%; 95% CI: -7 to 30 vs 44%; 95% CI: 24-59, test for interaction, P<0.05). However this effect was not detected in subjects who had contracted MA-fluA in the prior season. Conclusions Negative effects of repeated vaccination were significant among those without history of MA-fluA in the prior season.
Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies considered past influenza infection when assessing the VE of repeated vaccination. Prospective surveillance was conducted from 2009 to 2012 at a community hospital on a small island in Japan. The study included all outpatients with an influenza-like illness (ILI) who attended the hospital, and a rapid diagnostic test (RDT) was used to diagnose influenza A/B infection. The VE of trivalent inactivated influenza vaccine (TIV) against medically attended influenza A (MA-fluA) was estimated using a test-negative case-control study design. The influence of TIV in the prior season on VE in the current season was investigated in the context of MA-fluA during the prior season. During the three influenza seasons, 5838 ILI episodes (4127 subjects) were analysed. Subjects who had an episode of MA-fluA in the prior season were at a significantly lower risk of MA-fluA in the current season (adjusted odds ratio: 0.38, 95% CI: 0.30–0.50). The overall adjusted VE was 28% (95% CI, 14–40). VE was substantially lower in subjects vaccinated in the prior season compared to those who had not been vaccinated in prior season (19%; 95% CI: 0–35 vs 46%; 95% CI: 26–60, test for interaction, P value <0.05). In subjects who did not have MA-fluA in the prior season showed the attenuation of VE due to repeated vaccination (13%; 95% CI: −7 to 30 vs 44%; 95% CI: 24–59, test for interaction, P<0.05). However this effect was not detected in subjects who had contracted MA-fluA in the prior season. Negative effects of repeated vaccination were significant among those without history of MA-fluA in the prior season.
Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies considered past influenza infection when assessing the VE of repeated vaccination. Prospective surveillance was conducted from 2009 to 2012 at a community hospital on a small island in Japan. The study included all outpatients with an influenza-like illness (ILI) who attended the hospital, and a rapid diagnostic test (RDT) was used to diagnose influenza A/B infection. The VE of trivalent inactivated influenza vaccine (TIV) against medically attended influenza A (MA-fluA) was estimated using a test-negative case-control study design. The influence of TIV in the prior season on VE in the current season was investigated in the context of MA-fluA during the prior season. During the three influenza seasons, 5838 ILI episodes (4127 subjects) were analysed. Subjects who had an episode of MA-fluA in the prior season were at a significantly lower risk of MA-fluA in the current season (adjusted odds ratio: 0.38, 95% CI: 0.30-0.50). The overall adjusted VE was 28% (95% CI, 14-40). VE was substantially lower in subjects vaccinated in the prior season compared to those who had not been vaccinated in prior season (19%; 95% CI: 0-35 vs 46%; 95% CI: 26-60, test for interaction, P value <0.05). In subjects who did not have MA-fluA in the prior season showed the attenuation of VE due to repeated vaccination (13%; 95% CI: -7 to 30 vs 44%; 95% CI: 24-59, test for interaction, P<0.05). However this effect was not detected in subjects who had contracted MA-fluA in the prior season. Negative effects of repeated vaccination were significant among those without history of MA-fluA in the prior season.
Abstract Background Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies considered past influenza infection when assessing the VE of repeated vaccination. Methods Prospective surveillance was conducted from 2009 to 2012 at a community hospital on a small island in Japan. The study included all outpatients with an influenza-like illness (ILI) who attended the hospital, and a rapid diagnostic test (RDT) was used to diagnose influenza A/B infection. The VE of trivalent inactivated influenza vaccine (TIV) against medically attended influenza A (MA-fluA) was estimated using a test-negative case-control study design. The influence of TIV in the prior season on VE in the current season was investigated in the context of MA-fluA during the prior season. Results During the three influenza seasons, 5838 ILI episodes (4127 subjects) were analysed. Subjects who had an episode of MA-fluA in the prior season were at a significantly lower risk of MA-fluA in the current season (adjusted odds ratio: 0.38, 95% CI: 0.30–0.50). The overall adjusted VE was 28% (95% CI, 14–40). VE was substantially lower in subjects vaccinated in the prior season compared to those who had not been vaccinated in prior season (19%; 95% CI: 0–35 vs 46%; 95% CI: 26–60, test for interaction, P value <0.05). In subjects who did not have MA-fluA in the prior season showed the attenuation of VE due to repeated vaccination (13%; 95% CI: −7 to 30 vs 44%; 95% CI: 24–59, test for interaction, P < 0.05). However this effect was not detected in subjects who had contracted MA-fluA in the prior season. Conclusions Negative effects of repeated vaccination were significant among those without history of MA-fluA in the prior season.
Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies considered past influenza infection when assessing the VE of repeated vaccination.Prospective surveillance was conducted from 2009 to 2012 at a community hospital on a small island in Japan. The study included all outpatients with an influenza-like illness (ILI) who attended the hospital, and a rapid diagnostic test (RDT) was used to diagnose influenza A/B infection. The VE of trivalent inactivated influenza vaccine (TIV) against medically attended influenza A (MA-fluA) was estimated using a test-negative case-control study design. The influence of TIV in the prior season on VE in the current season was investigated in the context of MA-fluA during the prior season.During the three influenza seasons, 5838 ILI episodes (4127 subjects) were analysed. Subjects who had an episode of MA-fluA in the prior season were at a significantly lower risk of MA-fluA in the current season (adjusted odds ratio: 0.38, 95% CI: 0.30–0.50). The overall adjusted VE was 28% (95% CI, 14–40). VE was substantially lower in subjects vaccinated in the prior season compared to those who had not been vaccinated in prior season (19%; 95% CI: 0–35 vs 46%; 95% CI: 26–60, test for interaction, P value <0.05). In subjects who did not have MA-fluA in the prior season showed the attenuation of VE due to repeated vaccination (13%; 95% CI: −7 to 30 vs 44%; 95% CI: 24–59, test for interaction, P<0.05). However this effect was not detected in subjects who had contracted MA-fluA in the prior season.Negative effects of repeated vaccination were significant among those without history of MA-fluA in the prior season.
Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies considered past influenza infection when assessing the VE of repeated vaccination.BACKGROUNDAccumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies considered past influenza infection when assessing the VE of repeated vaccination.Prospective surveillance was conducted from 2009 to 2012 at a community hospital on a small island in Japan. The study included all outpatients with an influenza-like illness (ILI) who attended the hospital, and a rapid diagnostic test (RDT) was used to diagnose influenza A/B infection. The VE of trivalent inactivated influenza vaccine (TIV) against medically attended influenza A (MA-fluA) was estimated using a test-negative case-control study design. The influence of TIV in the prior season on VE in the current season was investigated in the context of MA-fluA during the prior season.METHODSProspective surveillance was conducted from 2009 to 2012 at a community hospital on a small island in Japan. The study included all outpatients with an influenza-like illness (ILI) who attended the hospital, and a rapid diagnostic test (RDT) was used to diagnose influenza A/B infection. The VE of trivalent inactivated influenza vaccine (TIV) against medically attended influenza A (MA-fluA) was estimated using a test-negative case-control study design. The influence of TIV in the prior season on VE in the current season was investigated in the context of MA-fluA during the prior season.During the three influenza seasons, 5838 ILI episodes (4127 subjects) were analysed. Subjects who had an episode of MA-fluA in the prior season were at a significantly lower risk of MA-fluA in the current season (adjusted odds ratio: 0.38, 95% CI: 0.30-0.50). The overall adjusted VE was 28% (95% CI, 14-40). VE was substantially lower in subjects vaccinated in the prior season compared to those who had not been vaccinated in prior season (19%; 95% CI: 0-35 vs 46%; 95% CI: 26-60, test for interaction, P value <0.05). In subjects who did not have MA-fluA in the prior season showed the attenuation of VE due to repeated vaccination (13%; 95% CI: -7 to 30 vs 44%; 95% CI: 24-59, test for interaction, P<0.05). However this effect was not detected in subjects who had contracted MA-fluA in the prior season.RESULTSDuring the three influenza seasons, 5838 ILI episodes (4127 subjects) were analysed. Subjects who had an episode of MA-fluA in the prior season were at a significantly lower risk of MA-fluA in the current season (adjusted odds ratio: 0.38, 95% CI: 0.30-0.50). The overall adjusted VE was 28% (95% CI, 14-40). VE was substantially lower in subjects vaccinated in the prior season compared to those who had not been vaccinated in prior season (19%; 95% CI: 0-35 vs 46%; 95% CI: 26-60, test for interaction, P value <0.05). In subjects who did not have MA-fluA in the prior season showed the attenuation of VE due to repeated vaccination (13%; 95% CI: -7 to 30 vs 44%; 95% CI: 24-59, test for interaction, P<0.05). However this effect was not detected in subjects who had contracted MA-fluA in the prior season.Negative effects of repeated vaccination were significant among those without history of MA-fluA in the prior season.CONCLUSIONSNegative effects of repeated vaccination were significant among those without history of MA-fluA in the prior season.
Author Suzuki, Motoi
Saito, Nobuo
Kishikawa, Takayuki
Yasaka, Takahiro
Morimoto, Kounosuke
Komori, Kazuhiro
Ariyoshi, Koya
Author_xml – sequence: 1
  givenname: Nobuo
  surname: Saito
  fullname: Saito, Nobuo
  organization: Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki, Japan
– sequence: 2
  givenname: Kazuhiro
  surname: Komori
  fullname: Komori, Kazuhiro
  organization: Kamigoto Hospital, Nagasaki, Japan
– sequence: 3
  givenname: Motoi
  surname: Suzuki
  fullname: Suzuki, Motoi
  organization: Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki, Japan
– sequence: 4
  givenname: Kounosuke
  surname: Morimoto
  fullname: Morimoto, Kounosuke
  organization: Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki, Japan
– sequence: 5
  givenname: Takayuki
  surname: Kishikawa
  fullname: Kishikawa, Takayuki
  organization: Kamigoto Hospital, Nagasaki, Japan
– sequence: 6
  givenname: Takahiro
  surname: Yasaka
  fullname: Yasaka, Takahiro
  organization: Kamigoto Hospital, Nagasaki, Japan
– sequence: 7
  givenname: Koya
  surname: Ariyoshi
  fullname: Ariyoshi, Koya
  email: kari@nagasaki-u.ac.jp
  organization: Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28043738$$D View this record in MEDLINE/PubMed
BookMark eNqNkt9qFDEUxoNU7Lb6CErAG29mTDKTTEZRKcW_FL1QwbuQZs6UrLPJmGQW1tfyBc24WwsLpQuBkPD7vnOS852gI-cdIPSYkpISKp4vy7U2xjooWT6WlJaE1ffQgsqmKhin8ggtCBN1UVPy4xidxLgkhPCKtg_QMZOkrppKLtCfz3Clk10DtqtRm4R9j8dgfcDW9cME7rfG20KZ8g7nZaYQwKVbAL3y7gqP4McBZgRMgg5r12Hn082FdbsyEXT07gU-wwliKtx1O0ZHKIx3KfgBxzR1m1nzSY_aPUT3ez1EeLTbT9H3d2-_nX8oLr68_3h-dlGYhvFUtExqrWXfVFxKSrgWgpuemwpq2bVEyqYXnWyI6FvWG8MENLImRlBSs15c0uoUPdv6jsH_mnJ3amWjgWHQDvwUFZVCVrRp6-oAlHMieC0PQWtRZUsxN_B0D136Kbj85tlQUsFawTP1ZEdNlyvoVP7XlQ4bdT3kDPAtYIKPMUD_H6FEzWFSS7ULk5rDpChVOUxZ93JPZ2z6N-UUtB3uVL_ZqiGPaG0hqGgsOAOdDTkDqvP2TofXew5msM4aPfyEDcSbv1CRKaK-znGf005FRUlDZ4NXtxsc0MBfXbMTrg
CitedBy_id crossref_primary_10_1097_EDE_0000000000001116
crossref_primary_10_1016_j_vaccine_2018_04_049
crossref_primary_10_1080_21645515_2020_1826250
crossref_primary_10_1016_j_vaccine_2020_10_074
crossref_primary_10_1016_j_cell_2022_11_012
crossref_primary_10_3390_v14030470
crossref_primary_10_2807_1560_7917_ES_2018_23_7_17_00026
crossref_primary_10_1016_j_vaccine_2017_03_063
crossref_primary_10_1093_cid_ciy202
crossref_primary_10_1080_14760584_2019_1586541
crossref_primary_10_1016_j_toxrep_2020_10_016
crossref_primary_10_1093_cid_ciy327
crossref_primary_10_1371_journal_pone_0198685
crossref_primary_10_1016_j_vaccine_2018_07_052
crossref_primary_10_1038_s41598_023_32537_0
crossref_primary_10_1016_j_vaccine_2023_03_066
crossref_primary_10_1080_21645515_2017_1423152
crossref_primary_10_1093_cid_ciy1009
crossref_primary_10_1021_acsnano_3c06526
crossref_primary_10_1080_14760584_2019_1675519
crossref_primary_10_1101_cshperspect_a038315
crossref_primary_10_11150_kansenshogakuzasshi_94_647
crossref_primary_10_1021_acs_jmedchem_2c01329
crossref_primary_10_1017_S0950268820002058
crossref_primary_10_1111_irv_70089
crossref_primary_10_3390_molecules27227797
crossref_primary_10_3390_vaccines9121447
crossref_primary_10_1016_j_vaccine_2017_06_088
crossref_primary_10_1016_j_vaccine_2018_04_037
crossref_primary_10_1016_j_antinf_2017_05_001
crossref_primary_10_1080_14760584_2019_1622418
crossref_primary_10_1080_14712598_2018_1391786
crossref_primary_10_1038_s41564_023_01505_9
crossref_primary_10_1016_j_vaccine_2018_01_023
crossref_primary_10_3390_v15020374
crossref_primary_10_3390_vaccines8010078
crossref_primary_10_3390_v12050520
crossref_primary_10_1016_S2213_2600_22_00266_1
crossref_primary_10_1080_14760584_2018_1470507
crossref_primary_10_1093_infdis_jiae220
crossref_primary_10_1186_s12979_019_0167_6
crossref_primary_10_3389_fimmu_2023_1133781
crossref_primary_10_1183_16000617_0258_2020
crossref_primary_10_1016_j_vaccine_2021_04_036
crossref_primary_10_1080_21645515_2018_1491246
crossref_primary_10_1038_s41572_018_0002_y
crossref_primary_10_1111_irv_12562
Cites_doi 10.1093/cid/cit255
10.2807/ese.18.05.20390-en
10.2807/1560-7917.ES2014.19.6.20701
10.15585/mmwr.mm6430a3
10.1016/S1473-3099(11)70295-X
10.1093/infdis/jiu650
10.1093/ije/dym021
10.1093/cid/cit060
10.1001/jama.1962.03050400013003
10.4049/jimmunol.0900398
10.1093/infdis/jiu651
10.1371/journal.pone.0027622
10.1016/S2213-2600(14)70034-7
10.1093/infdis/jiu580
10.1093/cid/ciw176
10.1016/j.vaccine.2016.01.054
10.1371/journal.pone.0088813
10.1016/S0264-410X(97)00003-0
10.1093/cid/ciu680
10.1371/journal.pmed.1000258
10.1056/NEJMoa0906453
10.1073/pnas.96.24.14001
10.1016/j.vaccine.2007.07.027
10.1093/cid/cis431
10.1371/journal.pone.0052103
10.1093/cid/cit736
10.1371/journal.pmed.1000388
10.1093/cid/cit750
10.1016/j.vaccine.2015.11.077
10.1093/infdis/jiv563
ContentType Journal Article
Copyright 2016 The Authors
The Authors
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.
Copyright Elsevier Limited Jan 23, 2017
Copyright_xml – notice: 2016 The Authors
– notice: The Authors
– notice: Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.
– notice: Copyright Elsevier Limited Jan 23, 2017
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7RV
7T2
7T5
7U9
7X7
7XB
88C
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9-
K9.
KB0
LK8
M0R
M0S
M0T
M1P
M2O
M7N
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7S9
L.6
7X8
DOI 10.1016/j.vaccine.2016.11.024
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Nursing & Allied Health Database
Health and Safety Science Abstracts (Full archive)
Immunology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Healthcare Administration Database (Alumni)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
AIDS and Cancer Research Abstracts
SciTech Premium Collection
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Biological Science Collection
Consumer Health Database
ProQuest Health & Medical Collection
Healthcare Administration Database
Medical Database
Research Library
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Health Management (Alumni Edition)
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Research Library
Health & Safety Science Abstracts
ProQuest Public Health
ProQuest Central Basic
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
Immunology Abstracts
ProQuest Central (Alumni)
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitleList Research Library Prep

MEDLINE

AGRICOLA

MEDLINE - Academic
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Veterinary Medicine
Biology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-2518
EndPage 693
ExternalDocumentID 4300730821
28043738
10_1016_j_vaccine_2016_11_024
S0264410X16310714
1_s2_0_S0264410X16310714
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Japan
INW, Japan
GeographicLocations_xml – name: Japan
– name: INW, Japan
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5RE
5VS
7-5
71M
7RV
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8P~
9JM
AAAJQ
AABNK
AAEDT
AAEDW
AAHBH
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABJNI
ABKYH
ABMAC
ABMZM
ABRWV
ABUWG
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACPRK
ACRLP
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEUYN
AEVXI
AEXOQ
AFKRA
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGGSO
AGUBO
AGYEJ
AHMBA
AIEXJ
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AQUVI
AXJTR
AZQEC
BBNVY
BENPR
BHPHI
BKEYQ
BKNYI
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CCPQU
CJTIS
CNWQP
CS3
DWQXO
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
FYUFA
G-Q
GBLVA
GNUQQ
GUQSH
HCIFZ
HMCUK
IHE
J1W
K9-
KOM
L7B
LK8
LUGTX
LW9
M0R
M0T
M1P
M29
M2O
M41
M7P
MO0
N9A
NAPCQ
O-L
O9-
O9~
OAUVE
OK0
OZT
P-8
P-9
P2P
PC.
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PUEGO
Q38
ROL
RPZ
SAB
SCC
SDF
SDG
SDP
SES
SNL
SPCBC
SSH
SSI
SSZ
T5K
UKHRP
UV1
WH7
WOW
Z5R
~G-
.GJ
29Q
3V.
AACTN
AAQXK
ABWVN
ABXDB
ACRPL
ADMUD
ADNMO
ADVLN
AFCTW
AFJKZ
AFKWA
AGHFR
AHHHB
AJOXV
ALIPV
AMFUW
ASPBG
AVWKF
AZFZN
FEDTE
FGOYB
G-2
HEJ
HLV
HMG
HMK
HMO
HVGLF
HX~
HZ~
R2-
RIG
SAE
SEW
SIN
SVS
WUQ
XPP
ZGI
ZXP
6I.
AAFTH
AAIAV
ABLVK
ABYKQ
AESVU
AJBFU
EFLBG
LCYCR
QYZTP
AAYXX
ACMHX
ADSLC
AGQPQ
AGRNS
AGWPP
AIGII
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T2
7T5
7U9
7XB
8FK
C1K
H94
K9.
M7N
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7S9
L.6
7X8
ID FETCH-LOGICAL-c725t-928aaa8f73588105a665cf5c3e48d90887f6d8706f92fcc26e7840c61042f6b13
IEDL.DBID .~1
ISSN 0264-410X
1873-2518
IngestDate Fri Jul 11 04:05:27 EDT 2025
Mon Jul 21 09:46:28 EDT 2025
Fri Jul 11 12:26:52 EDT 2025
Wed Aug 13 11:24:48 EDT 2025
Thu Apr 03 07:01:23 EDT 2025
Thu Apr 24 23:11:04 EDT 2025
Tue Jul 01 01:06:33 EDT 2025
Fri Feb 23 02:21:15 EST 2024
Tue Feb 25 20:03:51 EST 2025
Tue Aug 26 16:40:14 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Past influenza exposure
Repeated vaccination
Influenza
Vaccine effectiveness
Language English
License This is an open access article under the CC BY-NC-ND license.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c725t-928aaa8f73588105a665cf5c3e48d90887f6d8706f92fcc26e7840c61042f6b13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0264410X16310714
PMID 28043738
PQID 1858162965
PQPubID 105530
PageCount 7
ParticipantIDs proquest_miscellaneous_1868317943
proquest_miscellaneous_1855065483
proquest_miscellaneous_1846343361
proquest_journals_1858162965
pubmed_primary_28043738
crossref_primary_10_1016_j_vaccine_2016_11_024
crossref_citationtrail_10_1016_j_vaccine_2016_11_024
elsevier_sciencedirect_doi_10_1016_j_vaccine_2016_11_024
elsevier_clinicalkeyesjournals_1_s2_0_S0264410X16310714
elsevier_clinicalkey_doi_10_1016_j_vaccine_2016_11_024
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-01-23
PublicationDateYYYYMMDD 2017-01-23
PublicationDate_xml – month: 01
  year: 2017
  text: 2017-01-23
  day: 23
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
– name: Kidlington
PublicationTitle Vaccine
PublicationTitleAlternate Vaccine
PublicationYear 2017
Publisher Elsevier Ltd
Elsevier Limited
Publisher_xml – name: Elsevier Ltd
– name: Elsevier Limited
References Suzuki, Yoshimine, Harada, Tsuchiya, Shimada, Ariyoshi (b0155) 2013; 8
Ohmit, Thompson, Petrie, Thaker, Jackson, Belongia (b0075) 2014; 58
WHO. Influenza (seasonal): fact sheet number 211; 2014.
Ohmit, Petrie, Malosh, Johnson, Truscon, Aaron (b0105) 2016; 213
Grohskopf, Sokolow, Olsen, Bresee, Broder, Karron (b0010) 2015; 64
He, Holmes, Sanyal, Albrecht, Garcia-Sastre, Dekker (b0040) 2015; 211
Kissling, Valenciano, Buchholz, Larrauri, Cohen, Nunes (b0145) 2014; 19
Davenport (b0015) 1962; 182
Castilla, Navascues, Fernandez-Alonso, Reina, Pozo, Casado (b0050) 2016; 34
Ohmit, Petrie, Malosh, Cowling, Thompson, Shay (b0080) 2013; 56
Kissling, Valenciano, Cohen, Oroszi, Barret, Rizzo (b0130) 2011; 6
Thompson, Li, Shifflett, Sokolow, Ferber, Kurosky (b0115) 2014; 58
Keitel, Cate, Couch, Huggins, Hess (b0060) 1997; 15
Kim, Liepkalns, Reber, Lu, Music, Jacob (b0045) 2016; 34
Smith, Forrest, Ackley, Perelson (b0035) 1999; 96
Hancock, Veguilla, Lu, Zhong, Butler, Sun (b0140) 2009; 361
Suzuki, Minh Le, Yoshimine, Inoue, Yoshida, Morimoto (b0095) 2014; 9
Kim, Skountzou, Compans, Jacob (b0085) 2009; 183
Orenstein, De Serres, Haber, Shay, Bridges, Gargiullo (b0150) 2007; 36
[accessed on 28 April 2016].
Valenciano, Kissling, Cohen, Oroszi, Barret, Rizzo (b0125) 2011; 8
McLean, Thompson, Sundaram, Meece, McClure, Friedrich (b0070) 2014; 59
Hayward, Fragaszy, Bermingham, Wang, Copas, Edmunds (b0160) 2014; 2
Carrat, Flahault (b0025) 2007; 25
Kissling, Valenciano, Larrauri, Oroszi, Cohen, Nunes (b0135) 2013; 18
Skowronski, De Serres, Crowcroft, Janjua, Boulianne, Hottes (b0120) 2010; 7
National Institute of Infectious Disease in Japan. Flash report of influenza virus in Japan.
Skowronski, Janjua, De Serres, Winter, Dickinson, Gardy (b0020) 2012; 55
Osterholm, Kelley, Sommer, Belongia (b0030) 2012; 12
Sullivan, Kelly (b0065) 2013; 57
Skowronski, Chambers, Sabaiduc, De Serres, Winter, Dickinson (b0055) 2016; 63
Neuzil (b0090) 2015; 211
Ohmit, Petrie, Malosh, Fry, Thompson, Monto (b0100) 2015; 211
Osterholm (10.1016/j.vaccine.2016.11.024_b0030) 2012; 12
Castilla (10.1016/j.vaccine.2016.11.024_b0050) 2016; 34
Kissling (10.1016/j.vaccine.2016.11.024_b0135) 2013; 18
Skowronski (10.1016/j.vaccine.2016.11.024_b0020) 2012; 55
Skowronski (10.1016/j.vaccine.2016.11.024_b0055) 2016; 63
Ohmit (10.1016/j.vaccine.2016.11.024_b0080) 2013; 56
10.1016/j.vaccine.2016.11.024_b0110
Kissling (10.1016/j.vaccine.2016.11.024_b0130) 2011; 6
Sullivan (10.1016/j.vaccine.2016.11.024_b0065) 2013; 57
Hancock (10.1016/j.vaccine.2016.11.024_b0140) 2009; 361
Kim (10.1016/j.vaccine.2016.11.024_b0045) 2016; 34
Skowronski (10.1016/j.vaccine.2016.11.024_b0120) 2010; 7
He (10.1016/j.vaccine.2016.11.024_b0040) 2015; 211
Hayward (10.1016/j.vaccine.2016.11.024_b0160) 2014; 2
Valenciano (10.1016/j.vaccine.2016.11.024_b0125) 2011; 8
Suzuki (10.1016/j.vaccine.2016.11.024_b0155) 2013; 8
Davenport (10.1016/j.vaccine.2016.11.024_b0015) 1962; 182
Ohmit (10.1016/j.vaccine.2016.11.024_b0105) 2016; 213
Smith (10.1016/j.vaccine.2016.11.024_b0035) 1999; 96
Grohskopf (10.1016/j.vaccine.2016.11.024_b0010) 2015; 64
Kissling (10.1016/j.vaccine.2016.11.024_b0145) 2014; 19
Ohmit (10.1016/j.vaccine.2016.11.024_b0075) 2014; 58
Thompson (10.1016/j.vaccine.2016.11.024_b0115) 2014; 58
Neuzil (10.1016/j.vaccine.2016.11.024_b0090) 2015; 211
McLean (10.1016/j.vaccine.2016.11.024_b0070) 2014; 59
10.1016/j.vaccine.2016.11.024_b0005
Orenstein (10.1016/j.vaccine.2016.11.024_b0150) 2007; 36
Suzuki (10.1016/j.vaccine.2016.11.024_b0095) 2014; 9
Ohmit (10.1016/j.vaccine.2016.11.024_b0100) 2015; 211
Kim (10.1016/j.vaccine.2016.11.024_b0085) 2009; 183
Carrat (10.1016/j.vaccine.2016.11.024_b0025) 2007; 25
Keitel (10.1016/j.vaccine.2016.11.024_b0060) 1997; 15
References_xml – volume: 55
  start-page: 332
  year: 2012
  end-page: 342
  ident: b0020
  article-title: A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010–2011 season
  publication-title: Clin Infect Dis
– volume: 36
  start-page: 623
  year: 2007
  end-page: 631
  ident: b0150
  article-title: Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness
  publication-title: Int J Epidemiol
– volume: 182
  start-page: 11
  year: 1962
  end-page: 13
  ident: b0015
  article-title: Current knowledge of influenza vaccine
  publication-title: JAMA
– volume: 58
  start-page: 449
  year: 2014
  end-page: 457
  ident: b0115
  article-title: Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010–2011 and 2011–2012 influenza seasons
  publication-title: Clin Infect Dis
– volume: 58
  start-page: 319
  year: 2014
  end-page: 327
  ident: b0075
  article-title: Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates
  publication-title: Clin Infect Dis
– volume: 7
  start-page: e1000258
  year: 2010
  ident: b0120
  article-title: Association between the 2008–09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada
  publication-title: PLoS Med
– volume: 6
  year: 2011
  ident: b0130
  article-title: I-move multi-centre case control study 2010–11: overall and stratified estimates of influenza vaccine effectiveness in Europe
  publication-title: PLoS ONE
– volume: 57
  start-page: 474
  year: 2013
  end-page: 476
  ident: b0065
  article-title: Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required
  publication-title: Clin Infect Dis
– volume: 12
  start-page: 36
  year: 2012
  end-page: 44
  ident: b0030
  article-title: Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
  publication-title: Lancet Infect Dis
– volume: 211
  start-page: 1517
  year: 2015
  end-page: 1518
  ident: b0090
  article-title: How can we solve the enigma of influenza vaccine-induced protection?
  publication-title: J Infect Dis
– volume: 8
  start-page: e52103
  year: 2013
  ident: b0155
  article-title: Estimating the influenza vaccine effectiveness against medically attended influenza in clinical settings: a hospital-based case-control study with a rapid diagnostic test in Japan
  publication-title: PLoS ONE
– reference: National Institute of Infectious Disease in Japan. Flash report of influenza virus in Japan.
– volume: 361
  start-page: 1945
  year: 2009
  end-page: 1952
  ident: b0140
  article-title: Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus
  publication-title: N Engl J Med
– volume: 64
  start-page: 818
  year: 2015
  end-page: 825
  ident: b0010
  article-title: Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices, United States, 2015–16 influenza season
  publication-title: MMWR Morb Mortal Wkly Rep
– volume: 15
  start-page: 1114
  year: 1997
  end-page: 1122
  ident: b0060
  article-title: Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period
  publication-title: Vaccine
– volume: 8
  start-page: e1000388
  year: 2011
  ident: b0125
  article-title: Estimates of pandemic influenza vaccine effectiveness in Europe, 2009–2010: results of influenza monitoring vaccine effectiveness in Europe (I-MOVE) multicentre case-control study
  publication-title: PLoS Med
– volume: 34
  start-page: 1350
  year: 2016
  end-page: 1357
  ident: b0050
  article-title: Effectiveness of subunit influenza vaccination in the 2014–2015 season and residual effect of split vaccination in previous seasons
  publication-title: Vaccine
– volume: 211
  start-page: 1051
  year: 2015
  end-page: 1059
  ident: b0040
  article-title: Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination
  publication-title: J Infect Dis
– volume: 19
  start-page: 20701
  year: 2014
  ident: b0145
  article-title: Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13
  publication-title: Euro Surveill
– volume: 34
  start-page: 495
  year: 2016
  end-page: 502
  ident: b0045
  article-title: Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains
  publication-title: Vaccine
– volume: 9
  start-page: e88813
  year: 2014
  ident: b0095
  article-title: Vaccine effectiveness against medically attended laboratory-confirmed influenza in Japan, 2011–2012 season
  publication-title: PLoS ONE
– volume: 63
  start-page: 21
  year: 2016
  end-page: 32
  ident: b0055
  article-title: A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014–2015 season
  publication-title: Clin Infect Dis
– volume: 18
  year: 2013
  ident: b0135
  article-title: Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study
  publication-title: Euro Surveill
– reference: WHO. Influenza (seasonal): fact sheet number 211; 2014.
– volume: 183
  start-page: 3294
  year: 2009
  end-page: 3301
  ident: b0085
  article-title: Original antigenic sin responses to influenza viruses
  publication-title: J Immunol
– reference: [accessed on 28 April 2016].
– volume: 56
  start-page: 1363
  year: 2013
  end-page: 1369
  ident: b0080
  article-title: Influenza vaccine effectiveness in the community and the household
  publication-title: Clin Infect Dis
– volume: 2
  start-page: 445
  year: 2014
  end-page: 454
  ident: b0160
  article-title: Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study
  publication-title: Lancet Respir Med
– volume: 59
  start-page: 1375
  year: 2014
  end-page: 1385
  ident: b0070
  article-title: Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons
  publication-title: Clin Infect Dis
– volume: 96
  start-page: 14001
  year: 1999
  end-page: 14006
  ident: b0035
  article-title: Variable efficacy of repeated annual influenza vaccination
  publication-title: Proc Natl Acad Sci USA
– volume: 213
  start-page: 1229
  year: 2016
  end-page: 1236
  ident: b0105
  article-title: Substantial influenza vaccine effectiveness in households with children during the 2013–2014 influenza season, when 2009 Pandemic influenza A(H1N1) virus predominated
  publication-title: J Infect Dis
– volume: 211
  start-page: 1519
  year: 2015
  end-page: 1528
  ident: b0100
  article-title: Influenza vaccine effectiveness in households with children during the 2012–2013 season: assessments of prior vaccination and serologic susceptibility
  publication-title: J Infect Dis
– volume: 25
  start-page: 6852
  year: 2007
  end-page: 6862
  ident: b0025
  article-title: Influenza vaccine: the challenge of antigenic drift
  publication-title: Vaccine
– volume: 57
  start-page: 474
  issue: 3
  year: 2013
  ident: 10.1016/j.vaccine.2016.11.024_b0065
  article-title: Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cit255
– volume: 18
  issue: 5
  year: 2013
  ident: 10.1016/j.vaccine.2016.11.024_b0135
  article-title: Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study
  publication-title: Euro Surveill
  doi: 10.2807/ese.18.05.20390-en
– volume: 19
  start-page: 20701
  issue: 6
  year: 2014
  ident: 10.1016/j.vaccine.2016.11.024_b0145
  article-title: Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13
  publication-title: Euro Surveill
  doi: 10.2807/1560-7917.ES2014.19.6.20701
– volume: 64
  start-page: 818
  issue: 30
  year: 2015
  ident: 10.1016/j.vaccine.2016.11.024_b0010
  article-title: Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices, United States, 2015–16 influenza season
  publication-title: MMWR Morb Mortal Wkly Rep
  doi: 10.15585/mmwr.mm6430a3
– ident: 10.1016/j.vaccine.2016.11.024_b0110
– volume: 12
  start-page: 36
  issue: 1
  year: 2012
  ident: 10.1016/j.vaccine.2016.11.024_b0030
  article-title: Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(11)70295-X
– ident: 10.1016/j.vaccine.2016.11.024_b0005
– volume: 211
  start-page: 1519
  issue: 10
  year: 2015
  ident: 10.1016/j.vaccine.2016.11.024_b0100
  article-title: Influenza vaccine effectiveness in households with children during the 2012–2013 season: assessments of prior vaccination and serologic susceptibility
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiu650
– volume: 36
  start-page: 623
  issue: 3
  year: 2007
  ident: 10.1016/j.vaccine.2016.11.024_b0150
  article-title: Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/dym021
– volume: 56
  start-page: 1363
  issue: 10
  year: 2013
  ident: 10.1016/j.vaccine.2016.11.024_b0080
  article-title: Influenza vaccine effectiveness in the community and the household
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cit060
– volume: 182
  start-page: 11
  issue: 1
  year: 1962
  ident: 10.1016/j.vaccine.2016.11.024_b0015
  article-title: Current knowledge of influenza vaccine
  publication-title: JAMA
  doi: 10.1001/jama.1962.03050400013003
– volume: 183
  start-page: 3294
  issue: 5
  year: 2009
  ident: 10.1016/j.vaccine.2016.11.024_b0085
  article-title: Original antigenic sin responses to influenza viruses
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0900398
– volume: 211
  start-page: 1517
  issue: 10
  year: 2015
  ident: 10.1016/j.vaccine.2016.11.024_b0090
  article-title: How can we solve the enigma of influenza vaccine-induced protection?
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiu651
– volume: 6
  issue: 11
  year: 2011
  ident: 10.1016/j.vaccine.2016.11.024_b0130
  article-title: I-move multi-centre case control study 2010–11: overall and stratified estimates of influenza vaccine effectiveness in Europe
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0027622
– volume: 2
  start-page: 445
  issue: 6
  year: 2014
  ident: 10.1016/j.vaccine.2016.11.024_b0160
  article-title: Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(14)70034-7
– volume: 211
  start-page: 1051
  issue: 7
  year: 2015
  ident: 10.1016/j.vaccine.2016.11.024_b0040
  article-title: Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiu580
– volume: 63
  start-page: 21
  issue: 1
  year: 2016
  ident: 10.1016/j.vaccine.2016.11.024_b0055
  article-title: A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014–2015 season
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciw176
– volume: 34
  start-page: 1350
  issue: 11
  year: 2016
  ident: 10.1016/j.vaccine.2016.11.024_b0050
  article-title: Effectiveness of subunit influenza vaccination in the 2014–2015 season and residual effect of split vaccination in previous seasons
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2016.01.054
– volume: 9
  start-page: e88813
  issue: 2
  year: 2014
  ident: 10.1016/j.vaccine.2016.11.024_b0095
  article-title: Vaccine effectiveness against medically attended laboratory-confirmed influenza in Japan, 2011–2012 season
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0088813
– volume: 15
  start-page: 1114
  issue: 10
  year: 1997
  ident: 10.1016/j.vaccine.2016.11.024_b0060
  article-title: Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(97)00003-0
– volume: 59
  start-page: 1375
  issue: 10
  year: 2014
  ident: 10.1016/j.vaccine.2016.11.024_b0070
  article-title: Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciu680
– volume: 7
  start-page: e1000258
  issue: 4
  year: 2010
  ident: 10.1016/j.vaccine.2016.11.024_b0120
  article-title: Association between the 2008–09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1000258
– volume: 361
  start-page: 1945
  issue: 20
  year: 2009
  ident: 10.1016/j.vaccine.2016.11.024_b0140
  article-title: Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0906453
– volume: 96
  start-page: 14001
  issue: 24
  year: 1999
  ident: 10.1016/j.vaccine.2016.11.024_b0035
  article-title: Variable efficacy of repeated annual influenza vaccination
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.96.24.14001
– volume: 25
  start-page: 6852
  issue: 39–40
  year: 2007
  ident: 10.1016/j.vaccine.2016.11.024_b0025
  article-title: Influenza vaccine: the challenge of antigenic drift
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2007.07.027
– volume: 55
  start-page: 332
  issue: 3
  year: 2012
  ident: 10.1016/j.vaccine.2016.11.024_b0020
  article-title: A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010–2011 season
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cis431
– volume: 8
  start-page: e52103
  issue: 1
  year: 2013
  ident: 10.1016/j.vaccine.2016.11.024_b0155
  article-title: Estimating the influenza vaccine effectiveness against medically attended influenza in clinical settings: a hospital-based case-control study with a rapid diagnostic test in Japan
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0052103
– volume: 58
  start-page: 319
  issue: 3
  year: 2014
  ident: 10.1016/j.vaccine.2016.11.024_b0075
  article-title: Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cit736
– volume: 8
  start-page: e1000388
  issue: 1
  year: 2011
  ident: 10.1016/j.vaccine.2016.11.024_b0125
  article-title: Estimates of pandemic influenza vaccine effectiveness in Europe, 2009–2010: results of influenza monitoring vaccine effectiveness in Europe (I-MOVE) multicentre case-control study
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1000388
– volume: 58
  start-page: 449
  issue: 4
  year: 2014
  ident: 10.1016/j.vaccine.2016.11.024_b0115
  article-title: Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010–2011 and 2011–2012 influenza seasons
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cit750
– volume: 34
  start-page: 495
  issue: 4
  year: 2016
  ident: 10.1016/j.vaccine.2016.11.024_b0045
  article-title: Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2015.11.077
– volume: 213
  start-page: 1229
  issue: 8
  year: 2016
  ident: 10.1016/j.vaccine.2016.11.024_b0105
  article-title: Substantial influenza vaccine effectiveness in households with children during the 2013–2014 influenza season, when 2009 Pandemic influenza A(H1N1) virus predominated
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiv563
SSID ssj0005319
Score 2.4279537
Snippet Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published studies...
Abstract Background Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no...
Background Accumulating evidences indicate that repeated influenza vaccination has negative impact on the vaccine effectiveness (VE). However no published...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 687
SubjectTerms Adolescent
Adult
Aged
Aged, 80 and over
Allergy and Immunology
Case studies
Case-Control Studies
Child
Child, Preschool
Confidence intervals
Data analysis
Diagnostic tests
Epidemics
experimental design
Female
Health insurance
Hospitals
Hospitals, Community
Humans
Infant
Infant, Newborn
Infections
Influenza
Influenza Vaccines - administration & dosage
Influenza Vaccines - immunology
Influenza, Human - epidemiology
Influenza, Human - immunology
Influenza, Human - prevention & control
Japan
Japan - epidemiology
Local government
Male
Middle Aged
monitoring
odds ratio
Past influenza exposure
Patients
people
Population
Prospective Studies
Repeated vaccination
risk
Seasons
Treatment Outcome
vaccination
Vaccine effectiveness
Vaccines
Young Adult
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELZgCMQLgvKrMJCR0J7mLrEdx-UFTYhpmrRpEhvqm-U49tQJJaXNkMa_xT-Iz3aaF9oh5anxyUl9ufvOvvsOoY8uo04LNyU0NzXhtbZEl1VNpC2N4UILqSFQPD0Tx5f8ZFbM0obbKqVV9jYxGOq6NbBHfuD9iswFnYri8-Inga5RcLqaWmjcRw-Augy0upyVQ4oHC409fJjBCc-z2VDBc3A9-aUNHF1DdpeYAJEn5Zt80ybsGXzQ0VP0JIFHfBhX-xm6Z5sRehjbSd6O0KPTdFA-QnvnkZL6dh9fDBVWq328h88HsmovM_oO-TChKBf34s_RnzN7FRjBcayixK3Di-W8XeJ5bGryW-P4ZmFhsb9MJHraMCD0NMIxXR3HBDBbY93UuGm74Yd5k6aBrcu2-YQPsYfCHWn6xzHe6ZKUXo8DNS7InHiP37xAl0dfL74ck9TegZiSFh2ZUqm1lq5khZQe5mkhCuMKwyyXNaRflU7UcAzrptQZQ4UtfTRqPN7j1IkqZy_RTtM29jXCxmkJzduFFQW3lZbSyYpzO5VcVhUTY8T7hVUmcZ9DC44fqk9yu1ZJHxTog4-LlNeHMZqsxRaR_OMuAdFrjeorW70tVt493SVY_kvQrpJFWalcrajK1LcsINhs5nF0DsVnYyTXkgk0RTD0P5Pu9oqthnnW39kYfVjf9jYHDpJ0Y9sbGMMF44yJfNsYH_v61ZBs2xghWaAoHKNX8cNa_89URtatN9sf8i16TAFoZTmhbBftdMsb-87DxK56H2zBXxj-agU
  priority: 102
  providerName: ProQuest
Title Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0264410X16310714
https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X16310714
https://dx.doi.org/10.1016/j.vaccine.2016.11.024
https://www.ncbi.nlm.nih.gov/pubmed/28043738
https://www.proquest.com/docview/1858162965
https://www.proquest.com/docview/1846343361
https://www.proquest.com/docview/1855065483
https://www.proquest.com/docview/1868317943
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELemIRAvCMpXx0BGQnua28R2HIe3Um0qQ6sq2FDfLMexUSeUVG03aTzwT_EP4q-0IOiGkKIkSu5kJ77cneO73wHwxiTYSGYKhFNVIVpJjWReVojrXCnKJOPSTRRPx2x0Tk-m2XQHDNtcGBdWGXV_0OleW8cr_fg2-_PZrP8p8bY8mVqPInVpOC6DneZOynvffwnzIL64hyNGjnqTxdO_6F1J5ZavXYQX6zkwT0y32adt_qe3Q8cPwYPoQMJB6OMjsKPrDrgbSkped8C907hY3gEHkwBLfX0IzzZZVstDeAAnG8Bqy9P57GJifGIubNkfgx9j_cWjgsOQSQkbA-eLWbOAs1DY5JuE4cn84EK7qQD2tIXA1zWCIWQdhiAwXUFZV7BuVpsLszo2435fNvVbOIDWHV6huu2OsoYXxRB76OFxHc-Jtfr1E3B-fHQ2HKFY4gGpHGcrVGAupeQmJxnn1tWTjGXKZIpoyisXgpUbVrmlWFNgoxRmOrczUmV9PooNK1PyFOzWTa2fA6iM5K6AO9Mso7qUnBteUqoLTnlZEtYFtB1YoSL-uSvD8VW0gW4XIsqDcPJg50bCykMX9NZs8wAAchsDa6VGtNmtVh8La6JuY8z_xqiXUassRSqWWCTiD8nvAr7m_O3j-ZdG91vBFpt2eMZThguWdcHr9W2rd9xikqx1c-loKCOUEJbeRGPnv3Y0OLmJhnHiYQq74Fn4sNbvGfOAvLX3_8_3AtzHzhFLUoTJPthdLS71S-tGrspXXk_YfT7N7Z4P7fmdwfsPo7E9vjsaTz7-BCgqeO0
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGEB8vCMpXYICRYE9zlziO4yIhNA2m7qPVJDrUN-M4NuqEktJ2oPJH8cI_yDlOWh5ox8ukPqW-OK3P59_l7n6H0CsbUqu47RAa6ZywXBmi0iwnwqRaM664UM5R7PV594wdDZPhBvrV1MK4tMrGJlaGOi-1e0e-C-eKiDjt8OTd-BtxXaNcdLVpoeHV4tjMf4DLNn17-B7W9zWlBx8G-11SdxUgOqXJjHSoUEoJm8aJEIAuFOeJtomODRO5y_pJLc9d9M92qNWacpOCE6QBZjBqeRbFcN9r6DqLYWu6yvT9v1JK4qqRCLg1jLAoHC4rhnbP29-VdqFyl03G2444lLJVZ-EqrFudeQd30Z0arOI9r1330IYpWuiGb185b6GbvTow30Lbp54Ce76DB8uKrukO3sanS3JskGl9cvk3VREwbsTvo99986ViIMe-ahOXFo8no3KCR76Jyk-F_S-rFAnDR3tiqRUDqh5K2KfHY59wZnKsihwX5Wx5YVTU07hXpWXxBu9hgN4zUjSPo-GQJ3U6P66oeJ3MESCM4gE6u5KFf4g2i7IwjxHWVgnXLJ4bnjCTKSGsyBgzHcFElsU8QKxZWKlrrnXX8uOrbJLqzmWtD9LpA_hhEvQhQO2F2NiTjVwmwButkU0lLdh-CcfhZYLpvwTNtLZgUxnJKZWh_BhWiDkcAm6PXLFbgMRCsgZpHnz9z6RbjWLL5TyLfR2gl4uvwca5wJUqTHnhxjAew4bj0box4GvDaoh43Rgu4ooSMUCP_MZa_M9UeJavJ-sf8gW61R30TuTJYf_4KbpNHcgLI0LjLbQ5m1yYZwBRZ9nzyi5g9PmqDdEf-jSlPA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGEBMvCMpXYYCRYE9z29iO4yIhNG1U-2BVJTbUN-M4NuqEktJ2oPJv8cZfxzlOWh5ox8ukPqW-OK3Pd7-Lf3eH0CvXoU4L1yU0MhnhmbZEJ2lGpE2M4UILqX2geNoXh-f8eBgPN9DvOhfG0yprm1ga6qww_h15G_yKjATtirjtKlrE4KD3bvyN-A5S_qS1bqcRVOTEzn9A-DZ9e3QAa_2a0t77s_1DUnUYICah8Yx0qdRaS5ewWEpAGlqI2LjYMMtl5hlAiROZPwl0XeqMocImEBAZgBycOpFGDO57A91MWCL9HpP7f9FLWNlUBEIcTnjUGS6zh9oXre_a-GNzzywTLV9ElPJVfnEV7i39X-8uulMBV7wXNO0e2rB5A90KrSznDbR1Wh3SN9DOIJTDnu_is2V213QX7-DBslA2yDQ-eS5OmRCMa_H76FfffimrkeOQwYkLh8eTUTHBo9BQ5afG4ZeVSoXhY0KRqRUDyn5KOFDlcSCf2QzrPMN5MVteGOXVNP61aZG_wXsYYPiM5PXjGHD4pKL247Isr5c5BrSRP0Dn17LwD9FmXuT2McLGaekbxwsrYm5TLaWTKee2K7lMUyaaiNcLq0xVd923__iqaoLdhar0QXl9gJhMgT40UWshNg6FR64SELXWqDqrFvyAAtd4lWDyL0E7razZVEVqSlVHfeyU6LkzBAwf-cS3JpILyQqwBSD2P5Nu14qtlvMs9ngTvVx8DfbOH2Lp3BaXfgwXjDMmonVjIO6G1ZBs3RghWVkesYkehY21-J-pDBW_nqx_yBdoC0yQ-nDUP3mKblOP9zoRoWwbbc4ml_YZoNVZ-rw0Cxh9vm479AfJj6ly
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Negative+impact+of+prior+influenza+vaccination+on+current+influenza+vaccination+among+people+infected+and+not+infected+in+prior+season%3A+A+test-negative+case-control+study+in+Japan&rft.jtitle=Vaccine&rft.au=Saito%2C+Nobuo&rft.au=Komori%2C+Kazuhiro&rft.au=Suzuki%2C+Motoi&rft.au=Morimoto%2C+Kounosuke&rft.date=2017-01-23&rft.issn=0264-410X&rft.volume=35&rft.issue=4&rft.spage=687&rft.epage=693&rft_id=info:doi/10.1016%2Fj.vaccine.2016.11.024&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0264-410X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0264-410X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0264-410X&client=summon